trending Market Intelligence /marketintelligence/en/news-insights/trending/5SrPUGCXuQ7QctjBpxVQZg2 content esgSubNav
In This List

ImmunoCellular CEO resigns

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


ImmunoCellular CEO resigns

ImmunoCellular Therapeutics Ltd. CEO Andrew Gengos is resigning, though he will remain on the board.

The company appointed Anthony Gringeri to replace him.

Gringeri has been working at ImmunoCellular as senior vice president of strategic resources since August 2013.

The company said the change reflects its strategy to focus on the ICT-107 program, a dendritic-cell based immunotherapy that targets brain cancer stem cells.